Kenneth E. Carlson - Concepedia

Concepedia

Author

Kenneth E. Carlson

Bristol-Myers Squibb (United States)

Also Known As

K Carlson, K E Carlson, K. Carlson, Kenneth Carlson, Kenneth E Carlson, Kenneth E. Carlson

56

Publications

2.5K

Citations

26

H-Index

92

Concepts

All Affiliations

Bristol-Myers Squibb (United States)Harvard University University of Maryland, Baltimore Boston Children's Hospital University of Pennsylvania

KE

About

Kenneth E. Carlson is an author at Bristol-Myers Squibb (United States) specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	21	1.3K
2	Natural Sciences	5	5	257
3	Health Sciences	2	2	316
4	Engineering	1	1	64
5	Public Health	1	1	304

Kenneth E. Carlson

×

40

Publications

2.5K

Citations

26

H-Index

	Year	Citations
A human-airway-on-a-chip for the rapid identification of candidate antiviral therapeutics and prophylactics Longlong Si, Haiqing Bai, Melissa Rodas, Nature Biomedical Engineering Viral DiagnosticsRapid IdentificationMedicineCandidate Antiviral TherapeuticsAntiviral Response	2021	406
Geographic Variation in Opioid Prescribing in the U.S. Douglas McDonald, Kenneth E. Carlson, David Izrael Journal of Pain Opioid EpidemicSubstance AbuseSubstance UseHealth PolicyAddiction	2012	304
Thrombin and Phorbol Esters Cause the Selective Phosphorylation of a G Protein Other Than Gi in Human Platelets Kenneth E. Carlson, Lawrence F. Brass, David R. Manning Journal of Biological Chemistry Cellular PhysiologyThrombosisHuman PlateletsPhorbol Esters CauseHematology	1989	182
Pepducin targeting the C-X-C chemokine receptor type 4 acts as a biased agonist favoring activation of the inhibitory G protein Julie Quoyer, Jay M. Janz, Jiansong Luo, Proceedings of the National Academy of Sciences	2013	180
Discovery of a CXCR4 agonist pepducin that mobilizes bone marrow hematopoietic cells Boris Tchernychev, Yong Ren, Jay M. Janz, Proceedings of the National Academy of Sciences Cell TherapyImmunologyBlood CellBiological TherapyImmunotherapy	2010	112
Estimating the Prevalence of Opioid Diversion by “Doctor Shoppers” in the United States Douglas McDonald, Kenneth E. Carlson PLoS ONE	2013	110
Dual Angiotensin II and Endothelin A Receptor Antagonists: Synthesis of 2‘-Substituted N-3-Isoxazolyl Biphenylsulfonamides with Improved Potency and Pharmacokinetics Natesan Murugesan, Zhengxiang Gu, Leena Fadnis, Journal of Medicinal Chemistry Cardiovascular PharmacologyReceptor AntagonistPharmacotherapyMolecular PharmacologyMedicinal Chemistry	2004	86
Direct Interaction between an Allosteric Agonist Pepducin and the Chemokine Receptor CXCR4 Jay M. Janz, Yong Ren, Richard Looby, Journal of the American Chemical Society	2011	71
Chemoattractant-stimulated GTPase activity is decreased on membranes from polymorphonuclear leukocytes incubated in chemoattractant Mary W. Wilde, Kenneth E. Carlson, David R. Manning, Journal of Biological Chemistry	1989	69
Discovery of Tyrosine-Based Potent and Selective Melanocortin-1 Receptor Small-Molecule Agonists with Anti-inflammatory Properties Timothy F. Herpin, Guixue Yu, Kenneth E. Carlson, Journal of Medicinal Chemistry ImmunologyDermatologySkin PigmentationCompound 2Inflammation	2003	66

Page 1